Filter News Posts
VISIT US AT ARVO!
Robert Shimizu, PhD
Dr. Rob Shimizu brings over 35 years of corporate experience in ophthalmology ranging from research to development of pharmaceuticals, ocular devices, and combination products for diseases in both the anterior and posterior segments of the eye. ...
OCT Angiography Capabilities
OSOD now has the capability of performing non-invasive optical coherence tomography angiography with our Heidelberg Spectralis® instruments. We are currently exploring the utility on preclinical and pharmacology studies.
Welcome to the Executive Board!
OSOD is proud to welcome Dr. Craig Cross and Dr. Chuck O'Neill to the OSOD Executive Board. They each bring vast experience and new perspectives that go toward moving the company forward and increasing our capabilities.
Welcome, Reneé Smith!
Reneé Smith, a preclinical professional with over 25 years of experience in quality assurance (QA) and education, has joined the OSOD team. Reneé brings wide-ranging experience in all aspects of auditing and QA, including software validations....
Ala Moshiri, MD, PhD
We are pleased to annouce the addition of Dr. Ala Moshiri, Assistant Professor of Vitreoretinal Surgery and Uveitis at the UC Davis School of Medicine, to the clinical and investigative teams at OSOD. Dr. Moshiri brings extensive research ...
Carl Marfurt, PhD
OSOD is pleased to annouce that Dr. Carl Marfurt, Professor of Anatomy and Cell Biology at the Indiana University School of Medicine, has joined our team of vision scientists. Dr. Marfurt brings world-class experience and expertise in the areas...
Donald O. Mutti, OD, PhD
We are thrilled to welcome Dr. Donald O. Mutti to the OSOD vision science team. Dr. Mutti is the E.F. Wildermuth Foundation Professor of Optometry at The Ohio State University College of Optometry. His research career began in the contact lens...
Remembering Hank Edelhauser PHD
I knew Hank well as a fellow vision scientist with a focus on cornea, and in recent years as an important member of our consulting group that interacts with industry. He was a translational scientist of the highest order. Almost all of his...
Development of choroidal neovascularization in rats with advanced intense cyclic light-induced retinal degeneration
Histological evaluation of Wistar rats after 3 or 6 month of intense cyclic light exposure. Comparable H&E stained sections of retina of control (A, D) rats vs. intense light exposed rats (B, C, E, F), from central parts of retina were...